Literature DB >> 16648962

Assembly of HCV E1 and E2 glycoproteins into coronavirus VLPs.

N Jourdan1, G-J Godeke, M Penaud, G Mottola, A Sorrentino, P J M Rottier, S Bonatti.   

Abstract

Hepatitis C virus (HCV) is believed to assemble by budding into membranes of the early secretory pathway, consistent with the membrane location where the viral envelope glycoproteins E1 and E2 accumulate when expressed. Coronavirus assembly also takes place at pre-Golgi membranes. Here, we generated coronavirus-like particles carrying in their envelope chimeric HCV glycoproteins composed of the ectodomains of E1 and E2, each fused to the transmembrane plus endodomain of the mouse hepatitis coronavirus spike glycoprotein. The chimeric particle system will enable structural and functional studies of the HCV glycoproteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648962      PMCID: PMC7087226          DOI: 10.1007/s00705-006-0769-0

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  38 in total

1.  The Trojan exosome hypothesis.

Authors:  Stephen J Gould; Amy M Booth; James E K Hildreth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-28       Impact factor: 11.205

2.  Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly.

Authors:  H Vennema; L Heijnen; A Zijderveld; M C Horzinek; W J Spaan
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

3.  Robust hepatitis C virus infection in vitro.

Authors:  Jin Zhong; Pablo Gastaminza; Guofeng Cheng; Sharookh Kapadia; Takanobu Kato; Dennis R Burton; Stefan F Wieland; Susan L Uprichard; Takaji Wakita; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

4.  Characterization of pseudotype VSV possessing HCV envelope proteins.

Authors:  Y Matsuura; H Tani; K Suzuki; T Kimura-Someya; R Suzuki; H Aizaki; K Ishii; K Moriishi; C S Robison; M A Whitt; T Miyamura
Journal:  Virology       Date:  2001-08-01       Impact factor: 3.616

Review 5.  Functional hepatitis C virus envelope glycoproteins.

Authors:  Cécile Voisset; Jean Dubuisson
Journal:  Biol Cell       Date:  2004-08       Impact factor: 4.458

6.  Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding.

Authors:  J Klumperman; J K Locker; A Meijer; M C Horzinek; H J Geuze; P J Rottier
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

7.  Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin.

Authors:  P J Rottier; M C Horzinek; B A van der Zeijst
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

8.  Identification, by a monoclonal antibody, of a 53-kD protein associated with a tubulo-vesicular compartment at the cis-side of the Golgi apparatus.

Authors:  A Schweizer; J A Fransen; T Bächi; L Ginsel; H P Hauri
Journal:  J Cell Biol       Date:  1988-11       Impact factor: 10.539

9.  Enhancement of the vaccinia virus/phage T7 RNA polymerase expression system using encephalomyocarditis virus 5'-untranslated region sequences.

Authors:  H Vennema; R Rijnbrand; L Heijnen; M C Horzinek; W J Spaan
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

10.  Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons.

Authors:  Giovanna Mottola; Giorgia Cardinali; Alessandra Ceccacci; Caterina Trozzi; Linda Bartholomew; Maria Rosaria Torrisi; Emanuela Pedrazzini; Stefano Bonatti; Giovanni Migliaccio
Journal:  Virology       Date:  2002-02-01       Impact factor: 3.616

View more
  1 in total

Review 1.  Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C.

Authors:  Makutiro Ghislain Masavuli; Danushka K Wijesundara; Joseph Torresi; Eric J Gowans; Branka Grubor-Bauk
Journal:  Front Microbiol       Date:  2017-12-05       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.